275 related articles for article (PubMed ID: 19834276)
1. Refractory plasmablastic type myeloma with multiple extramedullary plasmacytomas and massive myelomatous effusion: remarkable response with a combination of thalidomide and dexamethasone.
Nakazato T; Suzuki K; Mihara A; Sanada Y; Kakimoto T
Intern Med; 2009; 48(20):1827-32. PubMed ID: 19834276
[TBL] [Abstract][Full Text] [Related]
2. A case of extramedullary plasmablastic plasmacytoma successfully treated using a combination of thalidomide and dexamethasone and a review of the medical literature.
Sekiguchi Y; Asahina T; Shimada A; Imai H; Wakabayashi M; Sugimoto K; Nakamura N; Sawada T; Komatsu N; Noguchi M
J Clin Exp Hematop; 2013; 53(1):21-8. PubMed ID: 23801130
[TBL] [Abstract][Full Text] [Related]
3. Myelomatous pleural effusion.
Ghosh S; Gopal R; Advani SH
J Assoc Physicians India; 2006 Sep; 54():738-9. PubMed ID: 17212026
[TBL] [Abstract][Full Text] [Related]
4. Pomalidomide-dexamethasone for treatment of soft-tissue plasmacytomas in patients with relapsed / refractory multiple myeloma.
Jiménez-Segura R; Granell M; Gironella M; Abella E; García-Guiñón A; Oriol A; Cabezudo E; Clapés V; Soler JA; Escoda L; López-Pardo J; Fernández de Larrea C; Cibeira MT; Tovar N; Isola I; Bladé J; Rosiñol L;
Eur J Haematol; 2019 May; 102(5):389-394. PubMed ID: 30719772
[TBL] [Abstract][Full Text] [Related]
5. Oral melphalan, dexamethasone, and thalidomide for the treatment of refractory multiple myeloma.
Asou N; Izuno Y; Okubo T; Ide K; Ueno H; Kawakita M; Mitsuya H; Hata H
Int J Hematol; 2007 Jul; 86(1):69-71. PubMed ID: 17675270
[TBL] [Abstract][Full Text] [Related]
6. [A clinical analysis of 25 cases of multiple myeloma complicated by extramedullary plasmacytomas].
Zhong YP; Chen SL
Zhonghua Nei Ke Za Zhi; 2009 May; 48(5):396-8. PubMed ID: 19615158
[TBL] [Abstract][Full Text] [Related]
7. Rapid response of plasmacytomas to lenalidomide plus low-dose dexamethasone therapy in a patient with relapsed multiple myeloma.
Fukushima T; Nakamura T; Iwao H; Umehara H
Am J Hematol; 2011 Oct; 86(10):893. PubMed ID: 21812018
[No Abstract] [Full Text] [Related]
8. Response of the extramedullary lung plasmacytoma with pleural effusion to chemotherapy.
Nagai K; Ando K; Yoshida H; Kusaka S; Hinuma Y; Hakamata Y; Ishii K; Kume N; Ochi H; Wakatsuki Y; Yokode M; Murakami M; Kita T
Ann Hematol; 1997 Jun; 74(6):279-81. PubMed ID: 9236513
[TBL] [Abstract][Full Text] [Related]
9. Bortezomib in combination with thalidomide and dexamethasone--a successful treatment regimen in refractory extramedullary multiple myeloma.
Dytfeld D; Matuszak M; Lewandowski K; Komarnicki M
Ann Hematol; 2008 Mar; 87(3):253-4. PubMed ID: 17955241
[No Abstract] [Full Text] [Related]
10. IgG myeloma presenting as a large mediastinal mass and pleural effusion.
Raci-Wetherbee E; Dincer HE
J Bronchology Interv Pulmonol; 2012 Jan; 19(1):65-7. PubMed ID: 23207268
[TBL] [Abstract][Full Text] [Related]
11. Bortezomib in relapsed multiple myeloma complicated by extramedullary plasmacytomas.
Hughes M; Micallef-Eynaud P
Clin Lab Haematol; 2006 Aug; 28(4):267-9. PubMed ID: 16898968
[TBL] [Abstract][Full Text] [Related]
12. The oral combination of thalidomide, cyclophosphamide and dexamethasone (ThaCyDex) is effective in relapsed/refractory multiple myeloma.
García-Sanz R; González-Porras JR; Hernández JM; Polo-Zarzuela M; Sureda A; Barrenetxea C; Palomera L; López R; Grande-García C; Alegre A; Vargas-Pabón M; Gutiérrez ON; Rodríguez JA; San Miguel JF
Leukemia; 2004 Apr; 18(4):856-63. PubMed ID: 14973508
[TBL] [Abstract][Full Text] [Related]
13. Solitary bone plasmacytoma terminally developed myeloma with multiple extramedullary lesions and myelomatous pleural effusion and ascites.
Matsumoto A; Nagata K; Hamaguchi H; Taki K
Int J Hematol; 1993 Dec; 59(1):59-65. PubMed ID: 8161736
[TBL] [Abstract][Full Text] [Related]
14. Myelomatous pleural effusion in multiple myeloma- A rare presentation.
Pradeep IY; Mayuri RK; Sourabh SP; Nirali MP
J Cancer Res Ther; 2024 Jan; 20(1):476-478. PubMed ID: 38554369
[TBL] [Abstract][Full Text] [Related]
15. Malignant myelomatous pleural effusion with good response to combination chemotherapy.
Attili VS; Singh VP; Sundar S; Mehta H; Negi ML; Gogia A; Raju SH; Rai M
J Assoc Physicians India; 2007 Aug; 55():595-6. PubMed ID: 18019805
[TBL] [Abstract][Full Text] [Related]
16. Low dose thalidomide in patients with relapsed or refractory multiple myeloma.
Kees M; Dimou G; Sillaber C; Drach J; Ackermann J; Lechner K; Gisslinger H
Leuk Lymphoma; 2003 Nov; 44(11):1943-6. PubMed ID: 14738147
[TBL] [Abstract][Full Text] [Related]
17. Treatment of relapsed multiple myeloma complicated by cardiac extramedullary plasmacytoma with D-PACE chemotherapy.
Toocheck C; Pinkhas D
BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29523615
[TBL] [Abstract][Full Text] [Related]
18. Two cases of permanent indwelling catheter for long-term administration of intrapleural chemotherapy.
Lázaro Sierra J; Carrasco V; Cases E; Gómez Gonzalez C
Arch Bronconeumol; 2017 Oct; 53(10):590-591. PubMed ID: 28359605
[No Abstract] [Full Text] [Related]
19. Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: a report of the Greek myeloma study group in 97 patients.
Katodritou E; Terpos E; Symeonidis AS; Pouli A; Kelaidi C; Kyrtsonis MC; Kotsopoulou M; Delimpasi S; Christoforidou A; Giannakoulas N; Viniou NA; Stefanoudaki E; Hadjiaggelidou C; Christoulas D; Verrou E; Gastari V; Papadaki S; Polychronidou G; Papadopoulou A; Giannopoulou E; Kastritis E; Kouraklis A; Konstantinidou P; Anagnostopoulos A; Zervas K; Dimopoulos MA
Am J Hematol; 2014 Aug; 89(8):803-8. PubMed ID: 24757085
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of extramedullary plasmacytoma of the cavernous sinus using a combination of intermediate dose of thalidomide and dexamethasone.
Katodritou E; Speletas M; Pouli A; Tsitouridis J; Zervas K; Terpos E
Acta Haematol; 2007; 117(1):20-3. PubMed ID: 17106187
[No Abstract] [Full Text] [Related]
[Next] [New Search]
